We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

17 hedge funds and large institutions have $15.6M invested in Acer Therapeutics Inc in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

32% more capital invested

Capital invested by funds: $11.8M → $15.6M (+$3.81M)

6% less funds holding

Funds holding: 18 → 17 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$2.07M
2
HA
Heartland Advisors
Wisconsin
+$1.87M
3
MWNA
Marshall Wace North America
New York
+$376K
4
BlackRock
BlackRock
New York
+$141K
5
UBS Group
UBS Group
Switzerland
+$27.1K

Top Sellers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
-$940K
2
PVI
Pura Vida Investments
New York
-$805K
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$385K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$254K
5
Wells Fargo
Wells Fargo
California
-$30.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$5.41M – – –
HA
2
Heartland Advisors
Wisconsin
$3.33M +$1.87M +98,400 +177%
ACP
3
Acuta Capital Partners
California
$2.36M +$2.07M +109,270 New
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$1.64M -$254K -13,389 -15%
JGC
5
J. Goldman & Co
New York
$879K -$940K -49,518 -55%
MWNA
6
Marshall Wace North America
New York
$861K +$376K +19,800 +99%
AAP
7
Ardsley Advisory Partners
Connecticut
$432K – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$264K – – –
BlackRock
9
BlackRock
New York
$168K +$141K +7,418 +2,016%
First Manhattan
10
First Manhattan
New York
$108K – – –
Wells Fargo
11
Wells Fargo
California
$102K -$30.3K -1,595 -25%
UBS Group
12
UBS Group
Switzerland
$31K +$27.1K +1,429 New
AIS
13
Accurate Investment Solutions
Pennsylvania
$1K – – –
JWA
14
JFS Wealth Advisors
Pennsylvania
$1K – – –
JP Morgan Chase
15
JP Morgan Chase
New York
$1K – – –
PVI
16
Pura Vida Investments
New York
– -$805K -41,795 Closed
Neuberger Berman Group
17
Neuberger Berman Group
New York
– -$385K -20,000 Closed
Bank of America
18
Bank of America
North Carolina
– -$8K -419 Closed
Morgan Stanley
19
Morgan Stanley
New York
– +$247 +13 +433%

ACER Hedge Fund Activity: Q2 2018 in Review

17 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2018, worth a combined $15.6M — up 32% from $11.8M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ACER and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.

The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $2.07M. The largest seller was J. Goldman & Co, cutting an estimated $940K.

  • 17 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2018, down from 18 in Q1 2018.
  • Funds reported $15.6M of Acer Therapeutics Inc stock for Q2 2018, up 32% quarter-over-quarter.
  • 2 funds opened new Acer Therapeutics Inc positions in Q2 2018 and 3 closed out, a net change of -1 holder.
  • The largest Acer Therapeutics Inc buyer in Q2 2018 was Acuta Capital Partners, an estimated $2.07M added.
  • The largest Acer Therapeutics Inc seller in Q2 2018 was J. Goldman & Co, an estimated $940K sold.

Based on aggregated 13F filings for Q2 2018.